Ally Pharma US Executes Merger

TAMPA, FL--(Marketwired - Dec 4, 2014) -  Ally Pharma US, Inc. (OTCBB: ALPHD) today announced that it completed a merger on September 30, 2014 with TPT Global Tech, Inc., a San Diego, California-based technology company.

The new direction of the company will be focused on communications and technology domestically and internationally. TPT Global Tech, Inc., will be under the direction of its new CEO, Mr. Stephen J. Thomas III.

For additional information about TPT Global Tech, Inc., please contact info@tptwireless.com.

About Ally Pharma US, Inc.
Ally Pharma US, Inc. (OTCBB: ALPHD) operates as a development stage biopharmaceutical company primarily in the United States. It focuses on the acquisition, licensing, and commercialization of pharmaceutical products and technologies, as well as homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, autoimmune, and infectious diseases.

The company is based in Tampa, Florida.